Question 1

Who are the top researchers at Biomedical Research Models (United States)?

Accepted Answer

Ranked on the quality score, Dennis L. Guberski lead among researchers whose main affiliation is Biomedical Research Models (United States).

Question 2

What are the most cited papers from Biomedical Research Models (United States)?

Accepted Answer

The most cited paper from Biomedical Research Models (United States) is "Ischemic Vascular Damage Can Be Repaired by Healthy, but Not Diabetic, Endothelial Progenitor Cells" (Sergio Caballero, Nilanjana Sengupta, Aqeela Afzal et al., 2007), with 263 citations. Next come "Lamin B1 fluctuations have differential effects on cellular proliferation and senescence" (251) and "Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock" (242).

Question 3

Which research topics does Biomedical Research Models (United States) publish most on?

Accepted Answer

By volume in 2022-now: Economic and Business Development Strategies, COVID-19, Geopolitics, Technology, Migration, Organizational Leadership and Management Strategies and Regional resilience and development.

Question 4

Which keywords describe research at Biomedical Research Models (United States)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Oxidative Stress, Inflammation, Type 1 Diabetes, Autoimmunity, Diabetes, Pancreatic Islets, ß-Cell Dysfunction and Environmental Management.

Question 5

Which fields of science does Biomedical Research Models (United States) work in?

Accepted Answer

In all years, 32% of research at Biomedical Research Models (United States) is in Social Sciences, 30% in Health Sciences. Its largest fields are Medicine (26%), Biochemistry, Genetics and Molecular Biology (13%), Social Sciences (10%). It does 1.4× the world's share of Social Sciences.

Question 6

Is Biomedical Research Models (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 166% higher than in 2018-2021.